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Background
The Brazilian National Cancer Institute (INCA) esti-
mated last year almost forty thousand new cancer cases
of laryngeal carcinoma, melanoma, tracheal, bronchial
and lung cancer. It is known that multidrug resistance
and unspecific toxicity are the major challenges for
commercial anticancer drugs [1]. In this regard, natural
compounds and derivatives are considered as a source
of novel antitumor drugs. Among these molecules, chal-
cones have gained pharmacological importance due its
mechanisms of action related to apoptosis induction [2].
Here we characterized the cytotoxicity of four chalcones
toward three tumor cell lines: Hep-2 (human laryngeal
squamous carcinoma cells), B-16 (mouse melanoma),
A549 (human lung adenocarcinoma epithelial cells) and
one normal cell line: 3T3 (mouse fibroblasts).
Methods
The cytotoxicity of chalcones was evaluated by the col-
orimetric MTT assay, which determines the reduction
of tetrazolium into insoluble formazan by mitochondria
of viable cells [3]. For this purpose, four chalcones:
trans-chalcone; Licochalcone A; 4-Methoxychalcone and
3’-(trifluoromethyl)chalcone were tested against four dif-
ferent cell lines: Hep-2, B-16, A549 and 3T3. The cell
culture was carried out by using Dulbecco’s Modified
Eagle Medium for A549 and 3T3, RPMI 1640 for Hep-2,
and F-10 for B-16. All medium were supplemented with
fetal calf serum. Each cell line was plated in a 96-well plate
(3x104 per well) for 24 hours before adding the medium
with chalcones in a 5 different concentration treatment
(25, 20, 15, 10 and 5 µg/mL). After 48 hours, compounds
were withdrawn and a solution of fresh medium contain-
ing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) was added. After 4 hours of incubation,
the product (formazan) was solved by DMSO. Hereafter,
the plates were measured through 550nm wavelength
analysis, using an ELISA reader. Treatments were com-
pared to negative control (medium with 0.25% DMSO)
and positive control (2.5 µg/mL doxorubicin). Cytotoxicity
was calculated by the formula: percent cytotoxicity =
(1-[absorbance of experimental wells/absorbance of con-
trol wells])×100% [4]. IC50 values were also determined.
Data were analyzed by the software Sisvar.
Results and conclusions
The IC50 values for A549 were 81.29 µM, 81.34 µM, 85.40
µM and 46.13 µM for trans-chalcone, 3’-(trifluoromethyl)
chalcone, 4-Methoxychalcone and Licochalcone A, respec-
tively. Hep-2 showed up the most susceptible cell line with
IC50 values below 10 µg/mL for trans-chalcone, Licochal-
cone A and 3’-(trifluoromethyl)chalcone. IC50 values for
Licochalcone A, trans-chalcone, 4-Methoxychalcone and
3’-(trifluoromethyl)chalcone for tumor mouse cell line
B-16 were, respectively, 25.89 µM, 45.42 µM, 50.15 µM
and 61.54 µM; for non-tumor mouse cell line 3T3 were
33.42 µM, 48.40 µM, 64.34 µM and 43.44 µM. All IC50
values for 4-Methoxychalcone were higher than 50 µM.
Thus, among the chalcones tested 4-Methoxychalcone
was the least cytotoxic and Licochalcone A the most effec-
tive for all cell lines, followed by trans-chalcone and
3’-(trifluoromethyl)chalcone.
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